Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Authors:

Abstract
No abstract available
Funding Information
  • Alexion Pharmaceuticals

This publication has 27 references indexed in Scilit: